🚀 VC round data is live in beta, check it out!
Eco Animal Health Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Eco Animal Health Group and similar public comparables like PolyPid, Gain Therapeutics, Fractyl Health, OSE Immunotherapeutics and more.
Eco Animal Health Group Overview
About Eco Animal Health Group
Eco Animal Health Group PLC is an animal health biotech company. It provides quality products for swine and poultry, anti-infectives to treat illness, improve health, and performance. Its products include Aivlosin/Valosin Solutions and Parasite Solutions. The company’s segments include Corporate/UK, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World, with the majority of the revenue deriving from China and Japan.
Founded
1984
HQ
Employees
219
Website
Financials (LTM)
EV
$72M
Eco Animal Health Group Financials
Eco Animal Health Group reported last 12-month revenue of $117M and EBITDA of $11M.
In the same LTM period, Eco Animal Health Group generated $56M in gross profit, $11M in EBITDA, and $4M in net income.
Revenue (LTM)
Eco Animal Health Group P&L
In the most recent fiscal year, Eco Animal Health Group reported revenue of $108M and EBITDA of $10M.
Eco Animal Health Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $117M | XXX | $108M | XXX | XXX | XXX |
| Gross Profit | $56M | XXX | $49M | XXX | XXX | XXX |
| Gross Margin | 48% | XXX | 45% | XXX | XXX | XXX |
| EBITDA | $11M | XXX | $10M | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 9% | XXX | XXX | XXX |
| EBIT Margin | 6% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $4M | XXX | $2M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 2% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Eco Animal Health Group Stock Performance
Eco Animal Health Group has current market cap of $90M, and enterprise value of $72M.
Market Cap Evolution
Eco Animal Health Group's stock price is $1.35.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $72M | $90M | -4.2% | XXX | XXX | XXX | $0.03 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEco Animal Health Group Valuation Multiples
Eco Animal Health Group trades at 0.6x EV/Revenue multiple, and 6.5x EV/EBITDA.
EV / Revenue (LTM)
Eco Animal Health Group Financial Valuation Multiples
As of April 18, 2026, Eco Animal Health Group has market cap of $90M and EV of $72M.
Equity research analysts estimate Eco Animal Health Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Eco Animal Health Group has a P/E ratio of 23.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $90M | XXX | $90M | XXX | XXX | XXX |
| EV (current) | $72M | XXX | $72M | XXX | XXX | XXX |
| EV/Revenue | 0.6x | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | 6.5x | XXX | 7.3x | XXX | XXX | XXX |
| EV/EBIT | 10.3x | XXX | 12.8x | XXX | XXX | XXX |
| EV/Gross Profit | 1.3x | XXX | 1.5x | XXX | XXX | XXX |
| P/E | 23.7x | XXX | 39.6x | XXX | XXX | XXX |
| EV/FCF | 40.9x | XXX | 9.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Eco Animal Health Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Eco Animal Health Group Margins & Growth Rates
Eco Animal Health Group's revenue in the last 12 month grew by 5%.
Eco Animal Health Group's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.
Eco Animal Health Group's rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Eco Animal Health Group's rule of X is 23% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Eco Animal Health Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Growth | 5% | XXX | 13% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 15% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 23% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| G&A Expenses to Revenue | 36% | XXX | 36% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 6% | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 41% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Eco Animal Health Group Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Eco Animal Health Group | XXX | XXX | XXX | XXX | XXX | XXX |
| PolyPid | XXX | XXX | XXX | XXX | XXX | XXX |
| Gain Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Fractyl Health | XXX | XXX | XXX | XXX | XXX | XXX |
| OSE Immunotherapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| AB Science | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Eco Animal Health Group M&A Activity
Eco Animal Health Group acquired XXX companies to date.
Last acquisition by Eco Animal Health Group was on XXXXXXXX, XXXXX. Eco Animal Health Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Eco Animal Health Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEco Animal Health Group Investment Activity
Eco Animal Health Group invested in XXX companies to date.
Eco Animal Health Group made its latest investment on XXXXXXXX, XXXXX. Eco Animal Health Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Eco Animal Health Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Eco Animal Health Group
| When was Eco Animal Health Group founded? | Eco Animal Health Group was founded in 1984. |
| Where is Eco Animal Health Group headquartered? | Eco Animal Health Group is headquartered in United Kingdom. |
| How many employees does Eco Animal Health Group have? | As of today, Eco Animal Health Group has over 219 employees. |
| Who is the CEO of Eco Animal Health Group? | Eco Animal Health Group's CEO is David Charles Hallas. |
| Is Eco Animal Health Group publicly listed? | Yes, Eco Animal Health Group is a public company listed on London Stock Exchange. |
| What is the stock symbol of Eco Animal Health Group? | Eco Animal Health Group trades under EAH ticker. |
| When did Eco Animal Health Group go public? | Eco Animal Health Group went public in 1995. |
| Who are competitors of Eco Animal Health Group? | Eco Animal Health Group main competitors are PolyPid, Gain Therapeutics, Fractyl Health, OSE Immunotherapeutics. |
| What is the current market cap of Eco Animal Health Group? | Eco Animal Health Group's current market cap is $90M. |
| What is the current revenue of Eco Animal Health Group? | Eco Animal Health Group's last 12 months revenue is $117M. |
| What is the current revenue growth of Eco Animal Health Group? | Eco Animal Health Group revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Eco Animal Health Group? | Current revenue multiple of Eco Animal Health Group is 0.6x. |
| Is Eco Animal Health Group profitable? | Yes, Eco Animal Health Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Eco Animal Health Group? | Eco Animal Health Group's last 12 months EBITDA is $11M. |
| What is Eco Animal Health Group's EBITDA margin? | Eco Animal Health Group's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of Eco Animal Health Group? | Current EBITDA multiple of Eco Animal Health Group is 6.5x. |
| What is the current FCF of Eco Animal Health Group? | Eco Animal Health Group's last 12 months FCF is $2M. |
| What is Eco Animal Health Group's FCF margin? | Eco Animal Health Group's last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of Eco Animal Health Group? | Current FCF multiple of Eco Animal Health Group is 40.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.